Breaking News

Abbott Expands Potent Manufacturing Capabilities

Adds granulation equipment at Sligo site

Abbott has expanded its manufacturing capabilities at its multi-product potent facility with the recent installment of a new roller compactor. The new granulation equipment for solid dose potent formulations, aims to provide customers with the greater flexibility and efficiency to advance their drug products. 
 
Abbott’s potent API and drug product contract manufacturing facility, located in Sligo, Ireland, also offers wet granulation, compression, coating and tableting processes for potent compounds.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters